Literature DB >> 12892127

Corynebacterium atypicum sp. nov., from a human clinical source, does not contain corynomycolic acids.

Val Hall1, Matthew D Collins2, Roger A Hutson2, Paul A Lawson2, Enevold Falsen3, Brian I Duerden1.   

Abstract

An unusual gram-positive, facultatively anaerobic, catalase-positive, diphtheroid-shaped organism originating from an unknown human clinical source was characterized by biochemical, molecular chemical and molecular phylogenetic methods. Based on its morphological and biochemical characteristics and the presence of a murein based on meso-diaminopimelic acid, the unidentified organism was tentatively assigned to the genus Corynebacterium. However, the unknown organism was found to lack the distinctive, short-chain corynomycolic acids that are considered to be characteristic of this genus. Despite the absence of these characteristic lipids, comparative 16S rRNA gene sequencing showed that the unknown bacterium was phylogenetically a member of the genus Corynebacterium and was distinct from all currently known species. Based on both phenotypic and 16S rRNA sequence considerations, it is proposed that the unknown organism be classified as a novel species, Corynebacterium atypicum sp. nov. The type strain of C. atypicum is strain R2070T (=CCUG 45804T=CIP 107431T).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892127     DOI: 10.1099/ijs.0.02442-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  8 in total

1.  Genome-Based Taxonomic Classification of the Phylum Actinobacteria.

Authors:  Imen Nouioui; Lorena Carro; Marina García-López; Jan P Meier-Kolthoff; Tanja Woyke; Nikos C Kyrpides; Rüdiger Pukall; Hans-Peter Klenk; Michael Goodfellow; Markus Göker
Journal:  Front Microbiol       Date:  2018-08-22       Impact factor: 5.640

2.  Bacterial community associated with the intestinal tract of P. monodon in commercial farms.

Authors:  Sage Chaiyapechara; Wanilada Rungrassamee; Ittipon Suriyachay; Yanin Kuncharin; Amornpan Klanchui; Nitsara Karoonuthaisiri; Pikul Jiravanichpaisal
Journal:  Microb Ecol       Date:  2011-09-14       Impact factor: 4.552

3.  Comparative evolutionary genomics of Corynebacterium with special reference to codon and amino acid usage diversities.

Authors:  Shilpee Pal; Indrani Sarkar; Ayan Roy; Pradeep K Das Mohapatra; Keshab C Mondal; Arnab Sen
Journal:  Genetica       Date:  2017-09-18       Impact factor: 1.082

4.  Isolation of Corynebacterium tuscaniae sp. nov. from blood cultures of a patient with endocarditis.

Authors:  Philippe Riegel; Roberta Creti; Romano Mattei; Alfredo Nieri; Christina von Hunolstein
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Mycolic Acid Biosynthesis Genes in the Genome Sequence of Corynebacterium atypicum DSM 44849.

Authors:  Anna Tippelt; Sabrina Möllmann; Andreas Albersmeier; Sebastian Jaenicke; Christian Rückert; Andreas Tauch
Journal:  Genome Announc       Date:  2014-08-21

6.  Phylogenomic Reappraisal of Fatty Acid Biosynthesis, Mycolic Acid Biosynthesis and Clinical Relevance Among Members of the Genus Corynebacterium.

Authors:  Lynn G Dover; Amy R Thompson; Iain C Sutcliffe; Vartul Sangal
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

7.  Corynebacterium pseudotuberculosis may be under anagenesis and biovar Equi forms biovar Ovis: a phylogenic inference from sequence and structural analysis.

Authors:  Alberto Oliveira; Pammella Teixeira; Marcela Azevedo; Syed Babar Jamal; Sandeep Tiwari; Sintia Almeida; Artur Silva; Debmalya Barh; Elaine Maria Seles Dorneles; Dionei Joaquim Haas; Marcos Bryan Heinemann; Preetam Ghosh; Andrey Pereira Lage; Henrique Figueiredo; Rafaela Salgado Ferreira; Vasco Azevedo
Journal:  BMC Microbiol       Date:  2016-06-02       Impact factor: 3.605

8.  Phylogeny Trumps Chemotaxonomy: A Case Study Involving Turicella otitidis.

Authors:  Inwoo Baek; Mincheol Kim; Imchang Lee; Seong-In Na; Michael Goodfellow; Jongsik Chun
Journal:  Front Microbiol       Date:  2018-04-30       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.